S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
NYSE:SENS

Senseonics (SENS) Stock Price, News & Analysis

$0.70
-0.03 (-4.10%)
(As of 02/26/2024 ET)
Today's Range
$0.70
$0.75
50-Day Range
$0.50
$0.73
52-Week Range
$0.46
$1.05
Volume
3.00 million shs
Average Volume
2.38 million shs
Market Capitalization
$370.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.25

Senseonics MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
78.1% Upside
$1.25 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.23mentions of Senseonics in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.16) to ($0.13) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.04 out of 5 stars

Medical Sector

796th out of 942 stocks

Process Control Instruments Industry

11th out of 11 stocks


SENS stock logo

About Senseonics Stock (NYSE:SENS)

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense, Eversense XL, and Eversense E3 which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

SENS Stock Price History

SENS Stock News Headlines

SENS Jan 2026 1.500 put
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
SENS Mar 2024 0.500 call
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Senseonics Holdings Inc
Senseonics Holdings Inc SENS
Q3 2023 Senseonics Holdings Inc Earnings Call
Here's what Wall Street expects from Senseonics's earnings report
See More Headlines
Receive SENS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Senseonics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/09/2021
Today
2/26/2024
Next Earnings (Estimated)
3/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Process control instruments
Sub-Industry
N/A
Employees
121
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.25
High Stock Price Target
$2.00
Low Stock Price Target
$0.50
Potential Upside/Downside
+71.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$142.12 million
Net Margins
-158.75%
Pretax Margin
-158.75%

Debt

Sales & Book Value

Annual Sales
$16.39 million
Cash Flow
$0.30 per share
Book Value
($0.01) per share

Miscellaneous

Free Float
499,754,000
Market Cap
$385.64 million
Optionable
N/A
Beta
0.87
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Dr. Timothy T. Goodnow Ph.D. (Age 62)
    President, CEO & Director
    Comp: $1.34M
  • Dr. Mukul Jain (Age 51)
    Chief Operating Officer
    Comp: $767.65k
  • Mr. Kenneth L. Horton (Age 57)
    General Counsel & Corporate Development Advisor
    Comp: $702.33k
  • Dr. Francine Ratner Kaufman M.D. (Age 72)
    Chief Medical Officer & Director
  • Mr. Frederick T. Sullivan (Age 42)
    CFO, Secretary & Treasurer














SENS Stock Analysis - Frequently Asked Questions

Should I buy or sell Senseonics stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" SENS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SENS, but not buy additional shares or sell existing shares.
View SENS analyst ratings
or view top-rated stocks.

What is Senseonics' stock price target for 2024?

2 brokerages have issued twelve-month price targets for Senseonics' shares. Their SENS share price targets range from $0.50 to $2.00. On average, they expect the company's share price to reach $1.25 in the next twelve months. This suggests a possible upside of 78.1% from the stock's current price.
View analysts price targets for SENS
or view top-rated stocks among Wall Street analysts.

How have SENS shares performed in 2024?

Senseonics' stock was trading at $0.5701 at the beginning of 2024. Since then, SENS stock has increased by 23.1% and is now trading at $0.7020.
View the best growth stocks for 2024 here
.

When is Senseonics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 13th 2024.
View our SENS earnings forecast
.

How were Senseonics' earnings last quarter?

Senseonics Holdings, Inc. (NYSE:SENS) posted its earnings results on Tuesday, November, 9th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.04) by $0.12. The firm earned $3.53 million during the quarter, compared to the consensus estimate of $3.68 million. Senseonics had a negative trailing twelve-month return on equity of 111.66% and a negative net margin of 158.75%.

What guidance has Senseonics issued on next quarter's earnings?

Senseonics updated its FY 2023 earnings guidance on Tuesday, January, 30th. The company provided EPS guidance of for the period. The company issued revenue guidance of $22.0 million-$22.0 million, compared to the consensus revenue estimate of $21.8 million.

When did Senseonics IPO?

(SENS) raised $45 million in an initial public offering on Friday, March 18th 2016. The company issued 15,800,000 shares at a price of $2.85 per share. Leerink Partners, Canaccord Genuity and Raymond James acted as the underwriters for the IPO and BTIG was co-manager.

Who are Senseonics' major shareholders?

Senseonics' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (4.23%), Charles Schwab Investment Management Inc. (0.57%), Northern Trust Corp (0.19%), Mirae Asset Global Investments Co. Ltd. (0.13%), Pathstone Holdings LLC (0.10%) and Price T Rowe Associates Inc. MD (0.06%). Insiders that own company stock include Anthony R Raab, Douglas A Roeder, Douglas S Prince, Edward Fiorentino, Francine Kaufman, Mirasol Panlilio, Mukul Jain, Nick B Tressler, Sharon Larkin, Stephen P Defalco and Timothy T Goodnow.
View institutional ownership trends
.

How do I buy shares of Senseonics?

Shares of SENS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:SENS) was last updated on 2/26/2024 by MarketBeat.com Staff